Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 3Completed 2Active not recruiting 2Unknown 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Sarcoma 1Head & Neck 1

Conditions

Colorectal Neoplasms 16Rectal Neoplasms 4Colonic Neoplasms 4Stomach Neoplasms 3Neoplasm Metastasis 3Neoplasms 2Biliary Tract Neoplasms 2Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Metastatic Gastric Adenocarcinoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Gastric Cancer Adenocarcinoma Metastatic 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Dihydropyrimidine Dehydrogenase Deficiency 1Desmoid Tumors 1Craniopharyngioma 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Advanced/Metastatic Solid Tumors 1Advanced Solid Tumors 1Adenomatous Polyposis Coli 1Adenocarcinoma Of Esophagus 1

Interventions

Oxaliplatin 42Fluorouracil 27Capecitabine 24pembrolizumab 21S 1 (combination) 19Paclitaxel 19Leucovorin 16Nivolumab 13Docetaxel 13sintilimab 12Drug Therapy 12tislelizumab 10Trastuzumab 10Cisplatin 10Irinotecan 9Bevacizumab 8trastuzumab deruxtecan 7spartalizumab 7XELOX 7Surgical Procedures, Operative 7Radiotherapy 7Hyperthermic Intraperitoneal Chemotherapy 7Biopsy 7fludarabine 6disitamab vedotin 6Cyclophosphamide 6lenvatinib 5apatinib 5Specimen Handling 5Ramucirumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Stomach Neoplasms × trifluridine tipiracil drug combination × Clear all
NCT07212933 2025-10-08

RAK in GC

Chinese PLA General Hospital

Phase 2 Recruiting
90 enrolled
Gastrointestinal

Stomach Neoplasms

NCT04999761 2024-09-25

AB122 Platform Study

Taiho Pharmaceutical Co., Ltd.

Phase 1 Recruiting
917 enrolled
GastrointestinalHead & NeckSarcomaThoracic

Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Sarcoma, Alveolar Soft Part

NCT06102785 2023-10-26

Fruquintinib Combined With TAS102 for Advanced Gastric Cancer

Tianjin Medical University Cancer Institute and Hospital

Recruiting
30 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡